Tumour necrosis factor-alpha (TNF-α) gene polymorphism and expression in pre-eclampsia

Clinical and Experimental Immunology

Volumn 104, Issue 1, 1996, Pages 154-159

  Chen, G ^a,b   Wilson, R ^b   Wang, S H ^c   Zheng, H Z ^d   Walker, J J ^e   Mckillop, J H ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^d UNIVERSITY OF LONDON   (United Kingdom)

^e ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

gene; gene expression; hypertension; polymorphism; pregnancy; tumour necrosis factor

Indexed keywords

MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HYPERTENSION; PREECLAMPSIA; PRIORITY JOURNAL;

EID: 0029949205     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-647.x     Document Type: Article

References (39)

1. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA A1, B8 and DR3 alleles. J Exp Med 1993; 177:557-60.
2. Han J, Brown T, Beutler B. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosyntesis at the translational level. J Exp Med 1990; 171:465-75.
3. Han J, Huez G, Beutler B Interactive effects of the tumor necrosis factor promoter and 3′-untranslated regions. J Immunol 1991; 43:1843-8.
4. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 87:1233-7.
5. Abraham LJ, French MAH, Dawkins RL. Polymorphic MHC ancestral haplotypes after the activity of tumour necrosis factor-alpha. Clin Exp Immunol 1993; 92:14-8.
6. Stark JM. Pre-eclampsia and cytokine induced oxidative stress. Br J Obstet Gynaecol 1993; 100:105-9.
7. Orvieto R, Ben-Rafael Z. The role of cytokines in early detection of preeclampsia. Medical Hypothesis 1994; 43:315-8.
8. Fiers W. Tumor necrosis factor. FEBS Letters 1991; 285:199-212.
9. Yui J, Garcialloret M, Wegmann TG, Guilbert LJ. Cytotoxicity of tumor necrosis factor alpha and gamma interferon against primary human placental trophoblasts. Placenta 1994; 15:819-35.
10. Slungaard A, Vercellotti GM, Walker VG, Nelson RD, Jacob HS. Tumor necrosis factor/cachectin stimulates eosinophil oxidant production and toxicity toward human endothelium. J Exp Med 1990; 199:2025-41.
11. Kupfermine M, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor α is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994; 170:1752-9.
12. Visser W, Beckmann I, Bremer HA, Lim HL, Wallenburg HAS. Bioactive tumour necrosis factor α in pre-eclamptic patients with and without the HELLP syndrome. Br J Obstet Gynaecol 1994; 101:1081-2.
13. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CWG. Interleukin-6, tumor necrosis factor and soluble tumor necrosis factor receptors in women with preeclampsia. Br J Obstet Gynecol 1995; 102:20-25.
14. American College of Obstetricians and Gynecologists. Management of pre-eclampsia. Washington DC: Technical Bulletin, 1986; 19.
15. Chen G, Wilson R, Boyd P, McKillop JH, Leitch C, Walker JJ, Burdon RH. Nornal superoxide dismutase (SOD) gene in pregnancy-induced hypertension: is the decreased SOD activity a secondary phenomenon? Free Rad Res 1994; 21:59-66.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
17. Reed PW, Davies JL, Copeman JB et al. Chromosome-specific microsatellite set for fluorescence-based, semiautomated genome mapping. Nature Genetics 1994; 7:390-5.
18. Finotto S, Ohno I, Marshall JS et al. TNF-α production by eosinophils in upper airways inflammation (nasal polyposis). J Immunol 1994; 153:2278-89.
19. Meekins JW, McLaughlin PJ, West DC, McFadyen IR, Johnson PM. Endothelial cell activation by tumour necrosis factor-alpha (TNF-α) and the development of pre-eclampsia. Clin Exp Immunol 1994; 98:110-4.
20. Schiff E, Friedman SA, Baumann P, Sibai BM, Romero R. Tumor necrosis factor-α in pregnancies associated with preeclampsia or small-for-gestational newborns. Am J Obstet Gynecol 1994; 170:1224-9.
21. Dinarello CA, Celfand JA, Wolf SW. Anticytokine stategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993; 269:1829-35.
22. Kilpatrick DC, Liston WA, Gibson F, Livingstone J. Association between susceptibility to pre-eclampsia within families and HLA-DR4. Lancet 1989; ii:1063-5.
23. Hoff C, Peevy K, Giattina K, Spinnato JA, Peterson RDA. Maternal fetal HLA-DR relationships and pregnancy-induced hypertension. Obstet Gynecol 1992; 80:1007-12.
24. Peterson RD, Tuck-Muller CM, Spinnato JA, Peevy K, Giattina K, Hoff C. An HLA-haplotype associated with preeclampsia and intrauterine growth retardation. Am J Reprod Immunol 1994; 31:177-9.
25. Sibai BM. Immunologic aspects of preeclampsia. Clin Obstet Gynecol 1991; 34:27-34.
26. Hunt JS. Expression and regulation of the tumour necrosis factor-alpha gene in the female reproductive tract. Reprod Fertil Dev 1993; 5:141-53.
27. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rudgers GM, MaLanghlin MK. Lipid peroxidation in pregnancy: new perspectives on pre-eclampsia. Am J Obstet Gynecol 1989; 161:1025-34.
28. Maseki M, Nishigaki I, Hagihara M, Tomoda Y, Yagi K. Lipid peroxide levels and lipid content of serum lipoprotein fractions of pregnant subjects with or without pre-eclampsia. Clin Chim Acta 1981; 115:155-61.
29. Chen G, Wilson R, Cumming G, Walker JJ, McKillop JH. Intracellular and extracellular anti-oxidant buffering levels in erythrocytes from pregnancy-induced hypertension (PIH). J Human Hypertension 1994; 8:37-42.
30. 2 .J Clin Invest 1992; 89:794-802.
31. Chen G, Wilson R, Cumming G, Walker JJ, McKillop JH. Production of prostacyclin and thrombaxane A2 in mononuclear cells from preeclamptic women. Am J Obstet Gynecol 1993; 169:1106-11.
32. Chen G, Wilson R, McKillop JH, Walker JJ. The role of cytokines in the production of prostacyclin and thromboxane A2 in human mononuclear cells. Immunol Invest 1994; 23:269-79.
33. Stern DM, Kaiser E, Nawroth PP. Regulation of the coagulation system by vascular endothelial cells. Haemostasis 1988; 18:202-14.
34. Scarpati EM, Sadler JE. Regulation of endothelial cell coagulant properties. J Biol Chem 1989; 264:20705-13.
35. Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994; 171:944-8.
36. Yoshizumi M, Perrella MA, Jr Burnett JC, Lee MET. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 1993; 73:205-9.
37. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 1992; 267:16323-9.
38. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76:301-14.
39. Lyall F, Greer IA, Boswell F, Macara LM, Walker JJ, Kingdom JCP. The cell adhesion molecule VCAM-1 is selectively elevated in serum in preeclampsia. Br J Obstet Gynaecol 1994; 101:485-7.